The biochemical assessment of insulin resistance

Annals of Clinical Biochemistry

Volumn 44, Issue 4, 2007, Pages 324-342

  Borai, Anwar ^a   Livingstone, Callum ^a,b   Ferns, Gordon A A ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; STABLE ISOTOPE;

ACCURACY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLAMP; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FUNCTION TEST; GLUCOSE HOMEOSTASIS; GOLD STANDARD; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAVENOUS GLUCOSE TOLERANCE TEST; ISOTOPE ANALYSIS; MEDICAL RESEARCH; METABOLIC SYNDROME X; MOLECULAR BIOLOGY; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE;

EID: 34548043306     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307780945778     Document Type: Review

References (128)

1. Greeve J. Inhibition of the synthesis of apolipoprotein B-containing lipoproteins. Handb Exp Pharmacol 2005; 170: 483-517
2. Lee JM, Choudhury RP. Prospects for atherosclerosis regression: HDL elevation and other emerging therapeutic technologies. Heart 2007; 93: 559-64
3. Marckmann P. Dietary treatment of thrombogenic disorders related to the metabolic syndrome. Br J Nutr 2000; 83(Suppl 1): S121-6
4. Vega GL. Obesity, the metabolic syndrome and cardiovascular disease. Am Heart J 2001; 142: 1108-16
5. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-81
6. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-61
7. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453-8
8. Smart JL, Tolle V, Low MJ. Glucocorticoids exacerbate obesity and insulin resistance in neurone specific proopiomelanocortin-deficient mice. J Clin Invest 2006; 116: 495-505
9. Wills J, Watson JM, Hales CN, Phillips DI. The relation of fetal growth to insulin secretion in young men. Diabet Med 1996; 13: 773-4
10. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87: 152-61
11. Haring H, Obermaier B, Ermel B, et al. Insulin receptor kinase defects as a possible cause of cellular insulin resistance. Diabet Metab 1987; 13: 284-93
12. Truglia JA, Livingston JN, Lockwood DH. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus. Am J Med 1985; 79: 13-22
13. Innes KE, Wimsatt JH. Pregnancy induced hypertension and insulin resistance: evidence for a connection. Acta Obstet Gynecol Scand 1999; 78: 263-84
14. Moran A, Jacobs DR, Steinberger J, et al. Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. J Clin Endocrinol Metab 2002; 87: 4817-20
15. Maron DJ, Fair JM, Haskell WL. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford coronary risk intervention project investigators and staff. Circulation 1991; 84: 2020-7
16. Gustat J, Elkasabany A, Srinivasan S, Berenson GS. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusu heart study. J Clin Epidemiol 2002; 55: 997-1006
17. Rodriguez A, Muller DC, Engelhardt M, Andres R. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore longitudinal study of aging. Metabolism 2005; 54: 542-7
18. Karnielli E, Cohen P, Barzilai N, et al. Insulin resistance in Cushing's syndrome. Horm Metab Res 1985; 17: 518-21
19. Wasada T, Aoki K, Sato A, et al. Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocr J 1997; 44: 617-20
20. Raza SA, DeWitt RT, Chen H, Warner TF, Blank RD. Catecholamine excess in phaeocromocytoma inducing insulin resistance. Endocr Pract 2004; 10: 149-52
21. Apridonidze T, Essah PA, Iuomo MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929-35
22. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7
23. Lin SY, Wang YY, Sheu WH. Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis. Metabolism 2004; 53: 922-66
24. Carlson GL. Hunterian lecture: Insulin resistance in human sepsis: implications for the nutritional and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl 2004; 86: 75-81
25. Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungkvist O. Insulin resistance after abdominal surgery. Br J Surg 1994; 81: 59-63
26. Carter EA. Insulin resistance after burns and trauma. Nutr Rev 1998; 56: S170-6
27. Braund W, Naylor BA, Williamson D, et al. Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Lancet 1987; 1: 237-40
28. Esposito DL, Li Y, Vanni C, et al. A novel T609R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signalling. J Clin Endocrinol Metab 2003; 88: 1468-75
29. Hansen L, Zethelius B, Berglund L, et al. In vitro and in vivo studies of a naturally occurring variant of the human p85alpha regulatory subunit of the phosphoinositide 3-kinase: inhibition of protein kinase B and relationships with type 2 diabetes, insulin secretion, glucose disappearance constant and insulin sensitivity. Diabetes 2001; 50: 690-3
30. Zhan S, Ho SC. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with insulin resistance. Obes Res 2005; 13: 1709-19
31. Livingstone C, Campbell IW, Dominiczak AF, Gould GW. Insulin resistance, hypertension and the insulin responsive glucose transporter (GLUT4). Clin Sci 1995; 89: 109-16
32. Krentz AJ. Insulin Resistance. A Clinical Handbook. Oxford: Blackwell, 2002
33. Barker DJ. Intrauterine programming of adult disease. Mol Med Today 1995; 1: 418-23
34. Tritos NA, Mantzoros CS. Syndromes of severe insulin resistance. J Clin Endocrinol Metab 1998; 83: 3025-30
35. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895-906
36. Bonora E, Moghetti P, Zancanaro C, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaemic and hyperglycaemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-8
37. Beard JC, Bergman RN, Ward WK, Porte D. The insulin sensitivity index in non-diabetic man: correlation between clamp-derived and IVGTT-derived values. Diabetes 1986; 35: 362-9
38. Duysinx BC, Scheen AJ, Gerard PL, Letiexhe MR, Paquot N, Lefebvre PJ. Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility. Diabetes Metab 1994; 20: 425-32
39. Saad MF, Anderson RL, Laws A, et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin resistance atherosclerosis study. Diabetes 1994; 43: 1114-21
40. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-70
41. Belfiore F, Ianello S, Camuto M, Fagone S, Cavaleri A. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese and obese-diabetic subjects. Metabolism 2001; 50: 573-82
42. Caumo A, Giacca A, Morgese M, Pozza G, Micossi P, Cobelli C. Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med 1991; 8: 822-32
43. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher BF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9
44. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10
45. Buren J, Lindmark S, Renstrom F, Eriksson JW. In vitro reversal of hyperglcemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism 2003; 52: 239-45
46. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 1993; 76: 275-8
47. Maddux BA, Chan A, Mandarino LJ, Goldfine ID. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 2006; 29: 1535-7
48. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23
49. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycaemic glucose clamp. J Clin Invest 1987; 79: 790-800
50. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86
51. Elahi D. In praise of the hyperglycaemic clamp. A method for assessment of b-cell sensitivity and insulin resistance. Diabetes Care 1996; 19: 278-86
52. Horgaard A, Thayssen TEH. Clinical investigation into the effect of the intravenous injection of insulin. Acta Med Scand 1929; 72: 92-5
53. Alford FP, Martin FI, Pearson MJ. The significance and interpretation of mildly abnormal oral glucose tolerance. Diabetologia 1971; 7: 173-80
54. Beck-Nielsen H. The pathogenic role of an insulin receptor defect in diabetes mellitus in the obese. Diabetes 1978; 27: 1175-81
55. Chen CC, Wang TY, Hsu SY, Chen RH, Chang CT, Chen SJ. Is the short insulin tolerance test safe and reproducible? Diabetes Med 1998; 15: 924-7
56. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-77
57. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-67
58. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS. Pre-type 1 diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes 1984; 33: 717-20
59. Pacini G, Bergman RN. MINMOD: a computer programme to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23: 113-22
60. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millenium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diab Technol Ther 2003; 5: 1003-15
61. Araujo-Vilar D, Rega-Liste CA, Garcia-Estevez DA, Sarmiento-Escalona F, Mosquera-Tallon V, Cabezas-Cerrato J. Minimal model of glucose metabolism: modified equations and its application in the study of insulin sensitivity in obese subjects. Diabetes Res Clin Pract 1998; 39: 129-41
62. Mehring GH, Coates PA, Brunel PC, Luzio SD, Owens DR. Insulin sensitivity in type 2 diabetes: univariate and multivariate techniques to derive estimates of insulin sensitivity from the insulin-modified intravenous glucose tolerance test (FSIGT). Comput Methods Programs Biomed 2002; 68: 161-76
63. Morbiducci U, Di Benedetto G, Kautzky-Willer A, Pacini G, Tura A. Improved usability of the minmal model of insulin sensitivity based on automated approach and genetic algorithms for parameter estimation. Clin Sci 2007; 112: 257-63
64. Boston RC, Moate PJ, Stefanovski D, Sumner AE. AKA Glucose: a program for kinetic and epidemiological analysis of FSIVGTT data using database technology. Diab Technol Ther 2005; 7: 298-307
65. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 1989; 38: 1512-27
66. Ader M, Pacini G, Yang YJ, Bergman RN. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal model prediction with direct measurements. Diabetes 1985; 34: 1092-3
67. Yang Y, Youn J, Bergman RN. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 1987; 253: E595-602
68. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin dependent diabetes. J Clin Endocrinol Metab 1990; 70: 1538-49
69. Alberti KGMM, Zimmet PZ. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva: World Health Organisation, 1999
70. Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose and FFA levels. Mol Genet Metab 1998; 63: 401-11
71. Carnevale Schianca GP, Sainaghi PP, Castello L, Rapetti R, Limoncini AM, Bartoli E. Comparison between HOMA-IR and ISI-gly in detecting subjets with the metabolic syndrome. Diab Metab Res Rev 2006; 22: 111-7
72. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-52
73. Haffner SM, Mietinnen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the seven year risk of non-insulin dependent diabetes mellitus in Mexican Americans. Diabetes 1995; 44: 1386-91
74. Stumvoll M, Mitrakou A, Pimenta W, et al. Assessment of insulin secretion from the oral glucose tolerance test in white patients with type-2 diabetes. Diabetes Care 2000; 23: 1440-1
75. Hosker JP, Matthews DR, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta cell function in man. Diabetologia 1985; 28: 401-11
76. Coggan AR. Use of stable isotopes to study carbohydrate and fat metabolism at the whole body level. Proc Nutr Soc 1999; 58: 953-61
77. Bowes EG, Hennessy TR, Umpleby AM, et al. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia 1996; 39: 976-83
78. 13C-glucose and gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Commun Mass Spectrom 2002; 16: 2009-14
79. 2H-labelled glucose compared for minimal model estimates of glucose metabolism in man. Clin Sci 2005; 109: 513-21
80. Bluck LJ, Clapperton AT, Coward WA. A stable isotope minimal model protocol with oral glucose administration. Rapid Commun Mass Spectrom 2006; 20: 493-8
81. Allick G, Bisschop PH, Ackermans MT, et al. A low carbohydrate/high fat diet improves glucoregulation in type-2 diabetes mellitus by reducing post-absorptive glycogenolysis. J Clin Endocrinol Metab 2004; 89: 6193-7
82. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care 2004; 27: 1487-95
83. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57-63
84. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2
85. Fukushima M, Taniguchi A, Sakai M, et al. Assessment of insulin sensitivity from single sample. Diabetes Care 2000; 23: 1434-5
86. Haffner SM, Gonzalez C, Miettinen H, Kennedy E, Stern MP. A prospective analysis of the HOMA model. Diabetes Care 1996; 19: 1138-41
87. Vanhala P, Vanhala M, Kumpusalo E, Keinanen-Kiukanniemi S. The quantitative insulin sensitivity check index QUICKI predicts the onset of type 2 diabetes better than fasting plasma insulin in obese subjects: a 5 year follow up study. J Clin Endocrinol Metab 2002; 87: 5834-7
88. Lee S, Choi S, Kim HJ, et al. Cut-off values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21: 695-700
89. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non-obese individuals. J Clin Endocrinol Metab 2001; 86: 4776-81
90. Rabasa-Lhoret R, Bastard JP, Jan V, et al. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinaemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin resistant states. J Clin Endocrinol Metab 2003; 88: 4917-23
91. Brady LM, Gower BA, Lovegrove SS, Williams CM, Lovegrove JA. Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model. Int J Obes Relat Metab Disord 2004; 28: 222-7
92. Bjorntorp P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1998; 4: 615-22
93. Krentz AJ, Dousset B, Mayer D, et al. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes 1993; 42: 1753-9
94. Turner RC, Holman RR. Pathophysiology of diabetes. Lancet 1976; 2: 856
95. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood. A statement for health professionals from the Committee on Atherosclerosis, Hypertension and Obesity in the Young (AHOY) of the Council on cardiovascular disease in the young, American Heart Association. Circulation 2002; 106: 143-60
96. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22
97. Krentz AJ, Singh BM, Nattrass M. Impaired glucose tolerance is characterised by multiple abnormalities in the regulation of intermediary metabolism. Diabet Med 1991; 8: 848-54
98. Krentz AJ, Clark PM, Cox L, Nattrass M. Hyperproinsulinaemia in impaired glucose tolerance. Clin Sci 1993; 85: 97-100
99. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-8
100. Nestler JE. Sex hormone binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 1993; 76: 273-4
101. Tchernof A, Labrie F, Belanger A, et al. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis 1997; 133: 235-44
102. Tchernof A, Toth MJ, Poehlman ET. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care 1999; 22: 1875-81
103. Goodman-Gruen D, Barrett-Connor E. A prospective study of sex hormone binding globulin and fatal cardiovascular disease in Ranch Bernardo men and women. J Clin Endocrinol Metab 1996; 81: 2999-3003
104. Lee PD, Conover CA, Powell DR. Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 1993; 204: 4-29
105. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319-57
106. Gibson JM, Westwood M, Young RJ, White A. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 1996; 81: 860-3
107. Hellenius ML, Brismar KE, Berglund BH, de Faire UH. Effects on glucose tolerance, insulin secretion, insulin-like growth factor-I and its binding protein IGFBP-1 in a randomised controlled diet and exercise study in healthy, middle aged men. J Intern Med 1995; 238: 121-30
108. Saitoh H, Kamoda T, Nakahara S, Hirano T, Matsui A. Insulin-like growth factor binding protein-1 (IGFBP-1) as a predictor of glucose stimulated hyperinsulinaemia in prepubertal obese children. Eur J Endocrinol 1999; 140: 231-4
109. Ebeling P, Stenman UH, Seppala M, Koivisto VA. Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man. J Endocrinol 1995; 146: 63-9
110. Kalme T, Loukovaara M, Koistinen R, Angervo M, Leinonen P, Seppala M. Estradiol increases the production of sex hormone-binding globulin but not insulin-like growth factor binding protein-1 in cultured human hepatoma cells. Fertil Steril 1999; 72: 325-9
111. Ye JH, Li ZZ, Li Y, et al. Relationship between serum interleukin-10 and insulin resistance in metabolic syndrome]. Nan Fang Yi Ke Da ZXue Xue Bao 2006; 26: 428-30
112. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000; 102: 42-7
113. Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res 2002; 10: 717-25
114. Taniguchi A, Fukushima M, Seino Y, et al. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2003; 52: 1246-9
115. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum gammaglutamyl transpeptidase (GGT) is a determinant of insulin resistance (HOMA-IR) independent of adiposity in Pima Indian Children. J Clin Endocrinol Metab 2006; 91: 1419-22
116. Bleicher M, Hogel J, Wudy S, et al. Insulin resistance (HOMA) in relation to plasma cortisol, IGF-I and IGFBP-3. A study in normal short-statured and GH deficient children. Horm Res 2002; 58: 229-32
117. Kocyigit Y, Bayhan G, Atamer A, Atamer Y. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia and their relationship to insulin resistance. Gynecol Endocrinol 2004; 18: 341-8
118. Lu HL, Wang HW, Wen Y, Zhang MX, Lin HH. Roles of adipocyte-derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 2006; 12: 1747-51
119. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 371-6
120. Kamoda T, Saitoh H, Inudoh M, Miyazaki K, Matsui A. The serum levels of proinsulin and their relationship with IGFBP-1 in obese children. Diabetes Obes Metab 2006; 8: 192-6
121. Krook A, O'Rahilly S. Mutant insulin receptors in syndromes of insulin resistance. Balliere's Clin Endocrinol Metab 1996; 10: 97-122
122. Mauriege P, Bouchard C. Trp64Arg mutation in beta-3 adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 1996; 348: 698-9
123. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Dunaif A. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signalling. Am J Physiol Endocrinol Metab 2005; 288: E1047-54
124. Braun B, Sharoff C, Chipkin SR, Beaudoin F. Effect of insulin resistance on substrate utilisation during exercise in overweight women. J Appl Physiol 2004; 97: 991-7
125. Permana PA, Nair S, Lee YH, et al. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 2004; 286: E958-62
126. Barbe P, Darimont C, Saint-Marc P, Galitzky J. Measurement of white adipose tissue metabolism by microdialysis techniques. Methods Mol Biol 2001; 155: 305-21
127. Shulman GI. Cellular mechanism of insulin resistance. J Clin Invest 2000; 106: 171-6
128. Nuutila P. Application of PET in research. Horm Metab Res 1997; 29: 337-9